Skip to content

Animal Assisted Intervention for Hemodialysis Outpatients

WithdrawnNot applicableNCT06030050
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The goal of this clinical trial is to understand if and how an animal-assisted intervention \[AAI\] using therapy dogs can support hemodialysis \[HD\] patients' treatment adherence and enhance their well-being. The main objectives are: * Objective 1: Determine if the AAI impacts patients' HD treatment adherence (primary outcome is number of unplanned missed treatments no due to hospitalization). * Objective 2: Evaluate if the AAI impacts patients' psychosocial well-being (secondary outcomes are stress, pain, mood, QOL). * Objective 3: Examine potential mechanistic biomarkers that underpin human-animal bonding (hormones tied to stress and bonding). (exploratory aim) * Objective 4: Understand patients' subjective experiences of the AAI. Participants will be asked to engage in several research tasks, including: * assessments * therapy dog visits * monthly blood draws * focus group Researchers will compare how the treatment group (those who receive 2 dogs visits per week) and the control group (those who receive 0 dog visits per week) to see if the AAI impacts treatment adherence and psychosocial well-being.

Study details

Official title
Animal Assisted Intervention for Hemodialysis Outpatients: A Mixed-method Randomized Controlled Trial for Treatment Adherence and Psychosocial Well-being
Conditions
Interventions
  • Behavioral: Animal-assisted intervention
Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
U.S. Renal Care, Inc.
Start date
2023-11-01
Primary completion
2024-01
Sex
All
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * current HD patient * aged 18+, * English speaking, -≥2 missed HD treatments in the last 90 days. Exclusion Criteria: * not an HD patient currently * aged younger than 18 years old * lacks proficiency in English speaking and reading * has only 1 or less missed HD treatments in the last 90 days.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06030050